SLC5A2 and diabetes mellitus: Table 3 details the diabetes medications they were taking at the time of their first attendance at the hub, with the majority (n = 133, 79.6%) of those referred to the hub taking metformin, and SGLT-2 medications representing the second most commonly utilised treatment for diabetes (n = 50, 29.9%).